Cytostatic treatment of glomerular diseases. III. A double-blind cross-over study of the effect of cyclophosphamide report from a copenhagen study group of renal diseases.

@article{Balslov1976CytostaticTO,
  title={Cytostatic treatment of glomerular diseases. III. A double-blind cross-over study of the effect of cyclophosphamide report from a copenhagen study group of renal diseases.},
  author={J T Balsl\oov and Claudia Brun and Poul Halberg and Klaus B. Jensen and F J\oorgensen and H E Jrgensen and Michael Larsen and Susanne Brink Larsen and I B Lorenzen and Amanda Thomsen},
  journal={Acta medica Scandinavica},
  year={1976},
  volume={200 1-2},
  pages={31-36}
}
Fifty patients with renal glomerular diseases entered a double-blind cross-over study on the effect of cyclophosphamide; 38 had received neither corticosteroids nor cytostatic drugs before joining the study. Cyclophosphamide was given for 4 months in doses decreasing from 3 to 1.5 mg/kg b.wt. Cyclophosphamide caused a 46% decrease in the 24-hour excretion… CONTINUE READING